… COVID-19 clinical trials landscape. Here, we present our assessment of ongoing COVID-19
therapeutic clinical development efforts worldwide. Surveying the clinical trial landscape …

… The COVID-19 vaccines in clinical trials have all shown promising immunogenicity with
varying degree of … Grade 3 or above side effects are not common in the clinical trials to date. …

… -controlled, randomised clinical trials (RCTs) of COVID-19 vaccine candidates once one or
… and future trials of other COVID-19 vaccine candidates currently in clinical development. …

… In this review, we found 24 clinical trials that have already started with the repositioning of
more than 20 medicines for COVID-19 treatment, such as human immunoglobulin, interferons, …

… Here, we review currently registered interventional clinical trials for the treatment and
prevention of COVID-19 to provide an overall summary and insight into the global response. …

… of the COVID-19 pandemic. In previous pandemics, large-scale randomized trials were …
of old-fashioned randomization, established clinical-trials networks and imaginative use of …

… Physical distancing to protect patient and researcher safety has been one of the major
disruptions to clinical trial research during COVID-19, but according to Kevin Sheth, chief of …

… controlled trials (RCTs) have reported highly variable efficacy results for COVID-19 CP (CCP),
resulting in uncertainty. We analyzed variables associated with efficacy, such as clinical …

… Our aim was to examine the association of the COVID-19 outbreak with new clinical trial …
of the COVID-19 outbreak with new clinical trial activations using data from ClinicalTrials.gov, a …

… COVID-19 disruption and the implications for the future conduct of clinical trials, we analysed
data from ClinicalTrials.gov between January and July 2020 and surveyed 245 clinical trial …